Brooklyn FI LLC Invests $441,000 in Oscar Health, Inc. (NYSE:OSCR)

Brooklyn FI LLC acquired a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 32,832 shares of the company's stock, valued at approximately $441,000.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Oscar Health by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after purchasing an additional 586,626 shares during the last quarter. Deerfield Management Company L.P. Series C grew its holdings in Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after acquiring an additional 3,983,325 shares during the last quarter. JPMorgan Chase & Co. increased its position in Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after acquiring an additional 8,051,379 shares in the last quarter. Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC lifted its position in shares of Oscar Health by 51.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after purchasing an additional 2,151,256 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now owns 64,512 shares of the company's stock, valued at $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 24.39% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

OSCR has been the subject of several analyst reports. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a research note on Thursday, May 22nd. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $20.08.

Oscar Health Stock Performance

Shares of NYSE OSCR traded down $1.09 during trading on Wednesday, reaching $13.92. 9,996,630 shares of the stock traded hands, compared to its average volume of 4,354,987. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market capitalization of $3.49 billion, a P/E ratio of -695.65 and a beta of 1.75. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a 50-day moving average of $13.74 and a 200-day moving average of $14.59.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The firm had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same period last year, the firm posted $0.62 earnings per share. The business's revenue was up 42.2% compared to the same quarter last year. Analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.